Analyses of simple repeat markers were performed as previously described.3 The venous malformation phenotype was analysed as an autosomal dominant disorder with age dependent penetrance. For estimating the age dependent penetrance, four liability classes were created with age ranges 0-12 (penetrance 0 5), 12-21 (penetrance 0-75) 21-45 (0 90), and >45 (0-95), based on observations from more than 10 years of clinical contact with the entire extended family. Disease frequency was set at 0-0001. Two point linkage analysis was performed on a Sun Sparc station 10 using the MLINK subprogram of the LINKAGE computer package (version 4-9).4 The analysis was repeated using the phenotypic information on only the affected subjects to ensure that information was coming only from those with a definitive disease status. Allele frequency was estimated for the markers using the pedigree maximum likelihood estimation from the family data by the method of Boehnke' and did not differ appreciably from the allele frequencies listed in GDB. dominant inheritance with variable age ofonset. Of 337 members of this very large, seven generation family, 56 people (29 males and 27 females) were affected. Fig 1 shows the portion of the family which participated in this study. Some of the members were born with lesions which never regressed, whereas others manifested new lesions later in life. Some of the affected members observed development of new vascular lesions after mechanical trauma. For example, in one subject, a large vascular mass appeared in the vagina after childbirth.
Most of the affected members had multiple venous malformations in various anatomical locations. In most cases, the lesions were present on the face and mucous membranes including the lips, the tongue, the cheeks, tonsils, and larynx (fig 2A, B) . Lesions were also noted on the trunk, the abdomen, and on the extremities including the fingers and feet. Some members had venous malformations within internal organs. One developed two vascular tumours in the large intestine and required blood transfusions because ofexcessive bleeding. Two members ofthis family died from complications of these vascular abnormalities. Pathological examination of one of these people showed vascular tumours within the stomach, liver, pancreas, and spleen. The broad candidate region previously described for venous malformations coincides with that from the present report. The additional meioses provided by this family narrowed the candidate region to 19 cM. This region contains a number of potential genes including the interferon gene cluster and the MTS 1 (p 16) tumour supressor gene proposed to be involved in melanoma as well as other tumours.9 "' A search of the GDB and OMIM databases showed that none of the numerous angiogenic factors that have been described maps to this region." We have suggested a Knudson-like tumour suppressor hypothesis for the development of lesions seen in hereditary haemorrhagic telangiectasia.3 We propose a similar hypothesis for the development of the venous malformations in this family, also inherited in an autosomal dominant fashion. We suggest that this locus may represent a new (or unmapped) gene involved in vasculogenesis, and that development of a venous malformation requires a second somatic mutation in a discrete progenitor cell.
